Cite Filings / ADPT / 0000950170-24-023095
Feed Companies Filings Check
Sign in
10-K

Annual Report

Adaptive Biotechnologies Corp · Filed 2024-02-29 · Acc 0000950170-24-023095

Documents 1

  • 10-K Annual Report , adpt-20231231.htm

Around this filing

  • 2025-03-03 10-K Annual Report
  • 2024-03-06 4 Chief Scientific Officer acquired 354,610 shares (grant or award)
  • 2024-03-06 4 Chief Financial Officer sold 15,456 shares at $3.44 ($53,169)
  • 2024-03-06 4 CEO and Chairman sold 48,673 shares at an average $3.43 ($167,007)
  • 2024-03-06 4 Chief Commercial Officer, MRD sold 12,991 shares at an average $3.44 ($44,629)
  • 2024-02-29 10-K Annual Report
  • 2023-02-14 10-K Annual Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading adpt-20231231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…